Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4847598
Max Phase: Preclinical
Molecular Formula: C16H15N5O11S2
Molecular Weight: 517.45
Molecule Type: Unknown
Associated Items:
ID: ALA4847598
Max Phase: Preclinical
Molecular Formula: C16H15N5O11S2
Molecular Weight: 517.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc(/C(=N/OCC(=O)O)C(=O)N[C@@H]2C(=O)N3[C@@H]2S(=O)(=O)C[C@@H]2CC(=O)O[C@@]23C(=O)O)cs1
Standard InChI: InChI=1S/C16H15N5O11S2/c17-15-18-6(3-33-15)9(20-31-2-7(22)23)11(25)19-10-12(26)21-13(10)34(29,30)4-5-1-8(24)32-16(5,21)14(27)28/h3,5,10,13H,1-2,4H2,(H2,17,18)(H,19,25)(H,22,23)(H,27,28)/b20-9-/t5-,10+,13+,16+/m0/s1
Standard InChI Key: VDPURUJYIPVCQC-OGELVBSKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 517.45 | Molecular Weight (Monoisotopic): 517.0209 | AlogP: -3.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 244.95 | Molecular Species: ACID | HBA: 13 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.08 | CX Basic pKa: 3.59 | CX LogP: -3.40 | CX LogD: -8.97 |
Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.12 | Np Likeness Score: -0.16 |
1. Sato J, Kusano H, Aoki T, Shibuya S, Yokoo K, Komano K, Oguma T, Matsumoto S, Sato T, Yasuo K, Yamawaki K.. (2021) A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships., 46 [PMID:34450571] [10.1016/j.bmc.2021.116343] |
Source(1):